Trends in research on ChatGPT and adoption-related issues discussed in articles: a narrative review

Abstract

This review aims to provide guidance for those contemplating the use of ChatGPT, by sharing research trends and evaluation results discussed in various articles. For an objective and quantitative analysis, 1,105 articles published over a 7-month period, from December 2022 to June 2023, following the release of ChatGPT were collected. These articles were sourced from PubMed, Scopus, and Web of Science. Additionally, 140 research articles were selected, including archived preprints and Korean articles, to evaluate the performance of ChatGPT. The analysis of research trends revealed that related communities are rapidly and actively responding: the educational community is redefining its directions, the copyright and patent community is monitoring lawsuits related to artificial intelligence creations, the government is establishing laws to regulate and prevent potential harm, the journal publishing community is setting standards for whether artificial intelligence can be considered an author, and the medical community is publishing numerous articles exploring the potential of ChatGPT to support medical experts. A comparative analysis of research articles on ChatGPT’s performance suggests that it could serve as a valuable assistant in human intellectual activities and academic processes. However, its practical application requires careful consideration to overcome certain limitations. Both the general public and researchers should assess the adoption of ChatGPT based on accurate information, such as that provided in this review.

The emergence of generative artificial intelligence platforms in 2023, journal metrics, appreciation to reviewers and volunteers, and obituary

“…Many kinds of generative AI platforms appeared, including GPT-4, Bing, Gemini (former Bard), Claude.ai, Clova X, and Wrtn. The issues related to ChatGPT adoption discussed in research articles mainly dealt with passing tests, applicability in medical practice, and writing support [ 1 ].…”

“…Many kinds of generative AI platforms appeared, including GPT-4, Bing, Gemini (former Bard), Claude.ai, Clova X, and Wrtn. The issues related to ChatGPT adoption discussed in research articles mainly dealt with passing tests, applicability in medical practice, and writing support [1].Many manuscripts on generative AI have also been submitted to this journal. Most of them were accepted if the methods and interpretations were sound.…”